Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
-3%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$44.4B
AUM Growth
+$1.2B
(+2.8%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
6.26%
Top 10 Holdings %
Top 10 Hldgs %
17.65%
Holding
2,641
New
312
Increased
1,037
Reduced
994
Closed
281
Top Buys
| 1 |
Broadcom
AVGO
|
+$410M |
| 2 |
Salesforce
CRM
|
+$397M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$351M |
| 4 |
Boston Scientific
BSX
|
+$348M |
| 5 |
Intuitive Surgical
ISRG
|
+$286M |
Top Sells
| 1 |
Visa
V
|
+$575M |
| 2 |
Eli Lilly
LLY
|
+$532M |
| 3 |
Meta Platforms (Facebook)
META
|
+$386M |
| 4 |
Progressive
PGR
|
+$357M |
| 5 |
Lam Research
LRCX
|
+$271M |
Sector Composition
| 1 | Technology | 25.88% |
| 2 | Healthcare | 15.37% |
| 3 | Financials | 14.29% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 10.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Treace Medical Concepts
TMCI
$467M
| $270K | ﹤0.01% |
32,200
-15,700
| -33% | -$132K |
|
2027
Codexis
CDXS
$221M
| $268K | ﹤0.01% |
99,500
-304,200
| -75% | -$818K |
|
2028
United States Antimony
UAMY
$574M
| $268K | ﹤0.01% |
121,600
-108,100
| -47% | -$238K |
|
2029
Superior Group of Companies
SGC
$190M
| $267K | ﹤0.01% |
24,400
+5,500
| +29% | +$60.2K |
|
2030
Broadridge
BR
$29.6B
| $267K | ﹤0.01% |
1,100
-500
| -31% | -$121K |
|
2031
Badger Meter
BMI
$5.29B
| $266K | ﹤0.01% |
1,400
-100
| -7% | -$19K |
|
2032
Cable One
CABO
$913M
| $266K | ﹤0.01% |
+1,000
| New | +$266K |
|
2033
NewtekOne
NEWT
$307M
| $266K | ﹤0.01% |
+22,200
| New | +$266K |
|
2034
Perdoceo Education
PRDO
$2.17B
| $264K | ﹤0.01% |
10,500
-6,500
| -38% | -$164K |
|
|
QD
2035
Qudian
QD
$698M
| $264K | ﹤0.01% |
98,184
-9,900
| -9% | -$26.6K |
|
2036
Ameresco
AMRC
$1.31B
| $263K | ﹤0.01% |
+21,800
| New | +$263K |
|
2037
Artivion
AORT
$2B
| $263K | ﹤0.01% |
+10,700
| New | +$263K |
|
2038
Janus International
JBI
$1.39B
| $263K | ﹤0.01% |
36,500
-44,800
| -55% | -$323K |
|
2039
Shutterstock
SSTK
$719M
| $261K | ﹤0.01% |
14,000
-20,500
| -59% | -$382K |
|
2040
Cavco Industries
CVCO
$4.29B
| $260K | ﹤0.01% |
500
-1,700
| -77% | -$883K |
|
2041
Entravision Communication
EVC
$226M
| $260K | ﹤0.01% |
123,700
-26,200
| -17% | -$55K |
|
|
TLN
2042
Talen Energy Corporation Common Stock
TLN
$17.8B
| $260K | ﹤0.01% |
1,300
-37,400
| -97% | -$7.47M |
|
2043
AZZ Inc
AZZ
$3.41B
| $259K | ﹤0.01% |
3,100
-5,400
| -64% | -$451K |
|
2044
Select Medical
SEM
$1.6B
| $259K | ﹤0.01% |
+15,500
| New | +$259K |
|
2045
Peoples Financial Services
PFIS
$525M
| $258K | ﹤0.01% |
+5,800
| New | +$258K |
|
|
TBI
2046
Trueblue
TBI
$165M
| $258K | ﹤0.01% |
48,500
-11,300
| -19% | -$60K |
|
2047
DXP Enterprises
DXPE
$1.88B
| $257K | ﹤0.01% |
3,127
-900
| -22% | -$74K |
|
2048
Neuropace
NPCE
$330M
| $257K | ﹤0.01% |
20,900
+10,400
| +99% | +$128K |
|
2049
Hudbay
HBM
$5.15B
| $256K | ﹤0.01% |
33,746
-749,400
| -96% | -$5.69M |
|
|
AUTL
2050
Autolus Therapeutics
AUTL
$365M
| $255K | ﹤0.01% |
164,700
-168,700
| -51% | -$261K |
|